Novotech recognized in Deloitte Technology Fast 500 Asia Pacific 2006 Program

Dec 12, 2006 – Sydney, Australia Novotech, the largest independent Australian owned contract research organization (CRO) and the only Australian CRO with offices in the USA, announced today that it is a winner in the Deloitte Fast 500 Asia Pacific 2006 Program. The Program run by the leading global consultancy, is supported by the Deloitte [...]

Novotech CRO opens second office in the USA

Oct 3, 2006 – Sydney, Australia — Novotech, the largest independent Australian owned contract research organization (CRO) announced today it has accelerated its US expansion plans with the opening of a second office in the USA specifically designed to service the maturing Australian biotech sector. Novotech CEO Alek Safarian said the new office in New [...]

Novotech presents checklist for CRO partnering and trials selection in Australia & Asia at DIA 2006

June 21, 2006 – Philadelphia, PA — Novotech, the largest Australian owned contract research organization (CRO) presented to the Drug Industry Association (DIA) annual conference 2006 this week, a check list for the selection of a CRO in Australia and the Asian region. At Novotech’s DIA press conference, Novotech CEO Alek Safarian said all eyes [...]

Novotech checklist for CRO partnering and trials selection is Australia & Asia

June 21, 2006 – Philadelphia, PA —Size match – ensure the CRO is a good match in organizational size and reach. Make sure the CRO has experience working with companies at a similar stage and growth phase, eg, small to medium sized biotechs often find it frustrating working with the large global CROs as they [...]

Novotech wins prestigious Asian CRO of The Year Award

June 20, 2006 – Philadelphia, PA — Novotech, the largest Australian owned contract research organization (CRO) announced today it has been recognized by Frost & Sullivan for its clinical research capabilities at the inaugural Asia Pacific Healthcare Best Practice Awards, winning The Asian CRO of the Year – Australia Award. According to Frost & Sullivan [...]

Novotech’s expansion to USA reaps multimillion

April 9, 2006 – Chigago, Il — Novotech, the largest Australian owned contract research organization (CRO) announced today at BIO 2006 in Chicago Il., an AUD4 million deal with US biotech firm SkyePharma (LSE: SKP; Nasdaq: SKYE) to conduct a key trial required for the US FDA. This is the first major deal for Novotech’s [...]